321: A New Concept of Continuous Gemcitabine Infusion: Fixed-Dose-Rate Gemcitabine Plus Platinum in Metastatic Transitional Cell Cancer-Preliminary Results of a Phase I Study | Zendy

AI Assistant Blog Pricing

321: A New Concept of Continuous Gemcitabine Infusion: Fixed-Dose-Rate Gemcitabine Plus Platinum in Metastatic Transitional Cell Cancer-Preliminary Results of a Phase I Study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.